What is Aviva Research?
Aviva Research operates at the intersection of clinical trial management and patient-centric healthcare delivery. The organization specializes in providing meticulous, accurate, and efficient research services designed to streamline the drug development lifecycle. By fostering organic relationships with both sponsors and the patient community, Aviva Research ensures that clinical studies are not only compliant and professional but also highly effective. Their unique approach emphasizes the role of the patient as a primary stakeholder, dedicating significant resources to participant satisfaction and engagement. This methodology allows the firm to maintain high standards of data integrity while accelerating the pace of medical discovery in the fight against complex diseases.
How much funding has Aviva Research raised?
Aviva Research has raised a total of $30K across 1 funding round:
Debt
$30K
Debt (2021): $30K with participation from PPP
Key Investors in Aviva Research
PPP
Public-Private Partnership
What's next for Aviva Research?
With this recent infusion of capital, Aviva Research is well-positioned to scale its operations and enhance its technological infrastructure. The company is expected to leverage these funds to expand its footprint in the clinical trial market, potentially increasing its capacity to manage larger, more diverse study cohorts. As the pharmaceutical industry continues to demand higher levels of professionalism and faster turnaround times, Aviva Research's focus on the front lines of clinical innovation provides a robust foundation for long-term growth. Future strategic initiatives will likely center on integrating advanced data analytics to further optimize study outcomes and solidify their reputation as a leader in the clinical research services landscape.
See full Aviva Research company page
